Author:
Facon Thierry,Dimopoulos Meletios A.,Meuleman Nathalie,Belch Andrew,Mohty Mohamad,Chen Wen-Ming,Kim Kihyun,Zamagni Elena,Rodriguez-Otero Paula,Renwick William,Rose Christian,Tempescul Adrian,Boyle Eileen,Manier Salomon,Attal Michel,Moreau Philippe,Macro Margaret,Leleu Xavier,Lorraine Chretien Marie,Ludwig Heinz,Guo Shien,Sturniolo Michael,Tinel Antoine,Silvia Monzini Mara,Costa Bruno,Houck Vanessa,Hulin Cyrille,Yves Mary Jean
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference23 articles.
1. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, et al. SEER cancer statistics review, 1975-2013.
http://seer.cancer.gov/csr/1975_2013/
. Updated September 12, 2016. Accessed Jan 2019.
2. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111:2516–20.
3. Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28:1122–28.
4. Palumbo A, Bringhen S, Mateos MV, Larocca A, Facon T, Kumar SK, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma: an International Myeloma Working Group report. Blood. 2015;125:2068–74.
5. Blagden SP, Charman SC, Sharples LD, Magee LR, Gilligan D. Performance status score: do patients and their oncologists agree? Br J Cancer. 2003;89:1022–27.